Description: ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others. The company was founded in 2004 and is based in Guildford, the United Kingdom.
Home Page: angleplc.com
Surrey Research Park
Guildford,
GU2 7AF
United Kingdom
Phone:
44 14 8334 3434
Officers
| Name | Title |
|---|---|
| Mr. Andrew David William Newland | Founder, CEO & Exec. Director |
| Mr. Ian Francis Griffiths | CFO, Fin. Director, Company Sec. & Exec. Director |
| Mr. Martin Cooke | Director of Operations & Regulatory Affairs |
| Mr. Andrew John Holder | Head of Investor Relations |
| Mr. Paul Smith | Chief Commercial Officer |
| Dr. Madeline Repollet | Head of Clinical Laboratories |
| Ms. Anne-Sophie Pailhes-Jimenez | Head of R&D - ANGLE Europe Ltd. |
| Mr. Michael O'Brien | Bus. Devel. Director |
Exchange: OTCQX
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.1982 |
| Price-to-Sales TTM: | 144.2354 |
| IPO Date: | |
| Fiscal Year End: | April |
| Full Time Employees: | 128 |